Advanced Optics Electronics Inc. Acquires ``Cox Color to Speech'' Processor.Business Editors ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Dec. 11, 2001 Advanced Optics Electronics Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ) has signed an agreement to complete development and market "ColorCheck"(TM) color to speech processor. "ColorCheck"(TM) is a small hand-held device that quickly determines the color of an object and enunciates the color. The target markets as identified by Advanced Optics Electronics Inc. and Dr. Brian Cox This article is about the actor. For the physicist, see Brian Cox (physicist). For the director, see Brian Cox (director). For the football player, see Bryan Cox. Brian Denis Cox, CBE (born June 1, 1946) is a Scottish actor. , the inventor will include the vision impaired, industrial applications and expansion into military use associated with thermal imaging. Sale price is projected at $97 per unit for an initial market of more than 3 million units. Advanced Optics Electronics Inc. is a technology company based in Albuquerque. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays A thin display screen for computer and TV usage. The first flat panels appeared on laptop computers in the mid-1980s, and the LCD technology became the standard. Stand-alone LCD screens became available for desktop computers in the mid-1990s and exceeded sales of CRTs for the first time utilizing its patented and patent-pending technology. ADOT currently holds three patents or patents pending. In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in BioModa Inc. BioModa Inc. (non public) is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . ADOT currently holds approximately 16 percent of BioModa Inc. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. with respect to the results of operations and business of the company that involves risk and uncertainties. The company's actual future results could materially differ from those discussed. Risks and uncertainties of the company will be detailed from time to time in the company's periodic reports to be filed with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion